Delivering nucleic acids to specific organs and cell types is a key challenge in developing future therapeutics, from rare genetic diseases to cancer. Lipid nanoparticles (LNPs) represent a tunable and modular platform for addressing many of these delivery challenges. However, screening LNPs for specific functions can be difficult due to the large number of possible components and formulation combinations.

Listen as Julie Rumble, Director of Immunology and Cell Biology at Cayman Chemical, joins Ben Knappett of Unchained Labs to provide practical insights into leveraging curated lipid libraries and streamlined characterization workflows to efficiently identify and assess promising LNP formulations.

Do you have a question or comment for the presenter? Let us know.